Skip to main content

Astrazeneca

 

Clinical courses

 

Clinical research courses

  • Work as Brand Leader at AstraZeneca

    AstraZeneca contributes meaningfully to the UK beyond the provision of our medicines and the benefits they provide to the health of the nation. We commissioned a report in 2009 to measure our significant investment to the UK economy, which includes investment in jobs and wealth creation. Oxera, an independent economic consultancy provided the analysis for this report. The report looks at our contribution to the UK as a whole as well as at individual countries within the UK, and at regions where AstraZeneca has a significant presence, identifying the company’s local impact in terms of spending, jobs and economic prosperity.

    Post : Brand Leader

  • Require Territory Business Manager at AstraZeneca

    AstraZeneca is an exciting global, innovation-driven biopharmaceutical company. We’re inspired by what science can do. Driven by the desire to meet unmet patient needs in our core therapeutic areas. Bold in our thinking. Proactive in pursuing discoveries beyond imagination. At sites across the world, we bring teams together in a spirit of collaboration to turn great ideas into life-changing medicines – strengthening our product portfolio and harnessing the potential of a pipeline across all stages of the drug development process.

    Post : Territory Business Manager

  • Work as SAP QCS Consultant at AstraZeneca | B.Pharm

    AstraZeneca is an exciting global, innovation-driven biopharmaceutical company. We’re inspired by what science can do. Driven by the desire to meet unmet patient needs in our core therapeutic areas. Bold in our thinking. Proactive in pursuing discoveries beyond imagination. At sites across the world, we bring teams together in a spirit of collaboration to turn great ideas into life-changing medicines – strengthening our product portfolio and harnessing the potential of a pipeline across all stages of the drug development process.

    Post : SAP QCS Consultant

  • Work as Pharmaceutical Sciences Intern at AstraZeneca | Waltham, USA

    AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. AstraZeneca is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines.

    Post : Pharmaceutical Sciences Intern

    (adsbygoogle = window.adsbygoogle || []).push({});
  • Vacancy for Associate Pharma Production at AstraZeneca

    AstraZeneca contributes meaningfully to the UK beyond the provision of our medicines and the benefits they provide to the health of the nation. We commissioned a report in 2009 to measure our significant investment to the UK economy, which includes investment in jobs and wealth creation. Oxera, an independent economic consultancy provided the analysis for this report.

    Post : Associate Pharma Production

  • AstraZeneca announced that it has entered into agreements that support its strategic focus on three main therapy areas; Respiratory, Inflammation and Autoimmunity, Cardiovascular and Metabolic disease and Oncology. The agreements include two of AstraZeneca’s potential new medicines for dermatitis and psoriasis, allowing the Company to further simplify and sharpen focus on innovative new medicines in the main therapy areas. 

  • Career in AstraZeneca as Business Performance Lead

    Global Technology Centre, Chennai is being established to provide high quality, scalable, cost effective IT services to the AstraZeneca global IT community. With a large pool of highly talented IT staff joining the centre in 2015, the centre will be very strategic in enabling AstraZeneca IT to achieve its overall objectives.  The leadership team of Chennai GTC (consisting of the AstraZeneca Chennai Site Lead, Tower Leads and Business Performance Lead) will focus on enabling the workforce to meet global organisational objectives of AstraZeneca IT - including ensuring high levels of service quality and delivery, as well as creating a Great Place to Work at AstraZeneca Chennai.  The Business Performance lead for Chennai GTC will be accountable to develop the strategy and measures to enable the Chennai centre to achieve its objectives in terms of quality, speed, efficiency, and service levels.

    Post: Business Performance Lead

  • AstraZeneca announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for sodium zirconium cyclosilicate (ZS-9), the investigational medicine being developed for the treatment of hyperkalaemia (high potassium level in the blood serum) by ZS Pharma, a wholly-owned subsidiary of AstraZeneca.

  • AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for the investigational MEK 1/2 inhibitor, selumetinib (AZD6244, ARRY-142886) for adjuvant treatment of patients with stage III or IV differentiated thyroid cancer (DTC). AstraZeneca acquired exclusive worldwide rights to selumetinib from Array BioPharma Inc. in 2003.

  • AstraZeneca has fulfilled the deal of the core respiratory business of Takeda Pharmaceutical Company Limited. The agreement, announced in December 2015.  Agreement includes the expansion of rights to roflumilast (marketed as Daliresp in the US and Daxas in other countries), the only approved oral PDE4 inhibitor for the treatment of chronic obstructive pulmonary disease. AstraZeneca marketed Daliresp in the US in the first quarter of 2015.

Subscribe to Astrazeneca